Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foquest Effect on Sleep in Children with ADHD
NCT04741516Phase 4Unknown
- Sponsor
- JPM van Stralen Medicine Professional Corporation
- Start
- Dec 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules, Implantable Devices
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by JPM van Stralen Medicine Professional Corporation. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04741516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741516.